Go Pro
→ $40,000,000,000,000 (From American Alternative) (Ad)tc pixel Free REVBW Stock Alerts

Revelation Biosciences (REVBW) Competitors

Revelation Biosciences logo
$0.0081 0.00 (-10.99%)
As of 09/18/2026 11:38 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

REVBW vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Revelation Biosciences stock or one of its competitors? Revelation Biosciences's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Revelation Biosciences compare to 60 Degrees Pharmaceuticals?

Revelation Biosciences (NASDAQ:REVBW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Revelation Biosciences. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Revelation Biosciences. Revelation Biosciences' average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
60 Degrees Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Revelation Biosciences on 2 of the 2 factors compared between the two stocks.

How does Revelation Biosciences compare to Biofrontera?

Revelation Biosciences (NASDAQ:REVBW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

In the previous week, Biofrontera had 1 more articles in the media than Revelation Biosciences. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Revelation Biosciences. Revelation Biosciences' average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
Biofrontera Neutral

Summary

Biofrontera beats Revelation Biosciences on 2 of the 2 factors compared between the two stocks.

How does Revelation Biosciences compare to Cingulate?

Revelation Biosciences (NASDAQ:REVBW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

In the previous week, Revelation Biosciences' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Summary

Revelation Biosciences and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.

How does Revelation Biosciences compare to Clever Leaves?

Revelation Biosciences (NASDAQ:REVBW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

Revelation Biosciences has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Revelation Biosciences' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
Clever Leaves Neutral

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Clever Leaves N/A N/A N/A

Summary

Clever Leaves beats Revelation Biosciences on 3 of the 3 factors compared between the two stocks.

How does Revelation Biosciences compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and Revelation Biosciences (NASDAQ:REVBW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Revelation Biosciences N/A N/A N/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Revelation Biosciences'average media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Revelation Biosciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

Summary

Comera Life Sciences beats Revelation Biosciences on 1 of the 1 factors compared between the two stocks.

Get Revelation Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for REVBW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding REVBW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

REVBW vs. The Competition

Export
MetricRevelation BiosciencesPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.49B$7.24B$12.95B
Dividend YieldN/A2.64%2.57%12.80%
P/E RatioN/A797.25275.4925.40
Price / SalesN/A759.04634.1882.03
Price / CashN/A86.3676.2551.42
Price / BookN/A10.5310.466.33
Net IncomeN/A$2.82B$3.49B$358.33M
7 Day PerformanceN/A1.69%0.59%1.12%
1 Month PerformanceN/A0.24%-1.74%-2.39%
1 Year PerformanceN/A3.95%18.13%5.35%

Revelation Biosciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
REVBW
Revelation Biosciences
N/A$0.01
-11.0%		N/A-38.6%$0.00N/AN/A10
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
flat		N/A-22.0%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.02
flat		N/A-80.7%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
flat		N/A-87.9%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/A-50.0%$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:REVBW) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners
$40,000,000,000,000
The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...
American Alternative | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
The Last Gold Bull Market?
Former CIA and Pentagon official Jim Rickards says the current gold bull market could be its last. Investment ...
Paradigm Press | Sponsoredtc pixel
Elon Musk to Trigger Next AI Wave on November 11th?
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
No Wallstreet. No Advisor. No Problem.
Savings accounts pay just 0.58 percent interest. Andy Howard, co-founder of Meridian Capital, says liquidity p...
Awesomely | Sponsoredtc pixel
The end of AI data centers coming?
Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...
Chaikin Analytics | Sponsoredtc pixel